Abstract
It was found that anti-biotics, aspirin, bisphosphonates, blood pressure lowering medications, statins, medications treating depression, diabetes, sexual dysfunction and the poly-pill provided economic value, while medications to treat Alzheimer’s, cancer, multiple sclerosis and Clopidogrel were not found to have provided economic value. The current evidence is insufficient to determine if weight loss medication provides economic value or not
Highlights
In the United States, the total amount of money spent on medications was approximately 511 billion dollars in 2019
Retail prescription drugs account for 10 percent of total National Health Expenditures in the United States
A recent review and analysis of non pharmacologic treatments for agitation and aggression in people with dementia concluded that non pharmacologic interventions seemed to be more effective than pharmacologic interventions for reducing aggression and agitation (Watt et al, 2019)
Summary
In the United States, the total amount of money spent on medications was approximately 511 billion dollars in 2019. Almost one in two people in the United States (or 46% of the population) used one or more prescription drugs in the last month between the years 2015–2016 (Pesce, 2019).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
